The stock is far too risky.

Teladoc Health, Inc. downgraded to Sell as revenue declines, BetterHelp shrinks, and member monetization weakens. Click for ...

Teladoc Health (NYSE: TDOC), the famed telemedicine specialist that rose to prominence in the early pandemic years, is not performing nearly as well as it once did. Over the past three years, the ...

Don't catch a falling knife.

Earlier this month, Teladoc Health expanded its long-running 24/7 Care virtual urgent care service, adding broader condition ...

Why Teladoc Health is on investors’ radar today Teladoc Health (TDOC) has been drawing fresh attention after a stretch of weak share performance, with the stock around $6.61 and negative returns over ...

Teladoc's revenue soared in 2020 and 2021 as online doctor's appointments made perfect sense in the coronavirus pandemic's lockdown phase. But the company's growth slowed dramatically after that ...

Citron Research identified Teladoc as a potential AI opportunity hiding in plain sight. While Teladoc's revenue has plateaued, its profitability has grown. The stock is quite cheap compared to ...

Teladoc Health, Inc.'s telehealth model struggles with low utilization despite its potential, leading to consistent operating losses and a declining average revenue per member. New CEO Chuck Divita ...

Teladoc Health (NYSE: TDOC) has struggled to navigate a shifting landscape in the virtual care industry. At the time of writing, the stock is down a disastrous 57% this year amid large recurring ...

Shares of Teladoc remain under pressure after the company projected a weak growth outlook. Its mental-health unit is facing intense competition from multiple digital-health startups. The market will ...